Merck & Co., Inc. (MRK)
USD 98.34
(-1.72%)
USD 98.34
(-1.72%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 6.9 Billion USD | -67.67% |
| 2022 | 21.31 Billion USD | 37.78% |
| 2021 | 17.89 Billion USD | 76.92% |
| 2020 | 10.18 Billion USD | -25.76% |
| 2019 | 16 Billion USD | 25.65% |
| 2018 | 13.99 Billion USD | 24.0% |
| 2017 | 11.95 Billion USD | -8.33% |
| 2016 | 10.79 Billion USD | 13.15% |
| 2015 | 12.44 Billion USD | -58.51% |
| 2014 | 24.7 Billion USD | 130.17% |
| 2013 | 13.33 Billion USD | -22.7% |
| 2012 | 16.43 Billion USD | 10.32% |
| 2011 | 15.51 Billion USD | -14.21% |
| 2010 | 9.74 Billion USD | 327.46% |
| 2009 | 18.32 Billion USD | -173.62% |
| 2008 | 11.81 Billion USD | -47.86% |
| 2007 | 13.06 Billion USD | 118.35% |
| 2006 | 5.98 Billion USD | -22.82% |
| 2005 | 7.75 Billion USD | 2.26% |
| 2004 | 7.58 Billion USD | -19.69% |
| 2003 | 9.43 Billion USD | -14.72% |
| 2002 | 11.06 Billion USD | 1.2% |
| 2001 | 10.93 Billion USD | 13.61% |
| 2000 | 9.62 Billion USD | 27.71% |
| 1999 | 7.53 Billion USD | 43.17% |
| 1998 | 5.26 Billion USD | -6.69% |
| 1997 | 5.64 Billion USD | 11.25% |
| 1996 | 5.07 Billion USD | 8.43% |
| 1995 | 4.67 Billion USD | -7.4% |
| 1994 | 5.05 Billion USD | 2.11% |
| 1993 | 4.94 Billion USD | 32.28% |
| 1992 | 3.74 Billion USD | 12.79% |
| 1991 | 3.31 Billion USD | 16.04% |
| 1990 | 2.85 Billion USD | 18.53% |
| 1989 | 2.41 Billion USD | 16.63% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 4.09 Billion USD | -24.04% |
| 2024 Q1 | 7.02 Billion USD | 1001.17% |
| 2024 Q2 | 7.33 Billion USD | 6.08% |
| 2023 Q4 | -455 Million USD | -106.32% |
| 2023 Q2 | -3.76 Billion USD | -182.59% |
| 2023 Q1 | 4.56 Billion USD | -4.26% |
| 2023 Q3 | 7.19 Billion USD | 291.0% |
| 2023 FY | - USD | -67.67% |
| 2022 Q4 | 4.76 Billion USD | -10.9% |
| 2022 FY | - USD | 37.78% |
| 2022 Q2 | 6.17 Billion USD | -12.06% |
| 2022 Q3 | 5.34 Billion USD | -13.44% |
| 2022 Q1 | 7.02 Billion USD | 45.82% |
| 2021 FY | - USD | 76.92% |
| 2021 Q1 | 3.84 Billion USD | 531.31% |
| 2021 Q2 | 2.56 Billion USD | -33.31% |
| 2021 Q3 | 5.69 Billion USD | 122.04% |
| 2021 Q4 | 4.81 Billion USD | -15.36% |
| 2020 Q2 | 3.48 Billion USD | -29.63% |
| 2020 FY | - USD | -25.76% |
| 2020 Q1 | 4.94 Billion USD | 22.37% |
| 2020 Q3 | 3.47 Billion USD | -0.03% |
| 2020 Q4 | -891 Million USD | -125.61% |
| 2019 Q1 | 4.45 Billion USD | 19.0% |
| 2019 Q2 | 4.49 Billion USD | 0.9% |
| 2019 Q3 | 3.67 Billion USD | -18.16% |
| 2019 FY | - USD | 25.65% |
| 2019 Q4 | 4.04 Billion USD | 9.9% |
| 2018 Q2 | 3.71 Billion USD | 35.42% |
| 2018 FY | - USD | 24.0% |
| 2018 Q1 | 2.74 Billion USD | -21.31% |
| 2018 Q3 | 3.96 Billion USD | 6.67% |
| 2018 Q4 | 3.74 Billion USD | -5.6% |
| 2017 Q4 | 3.48 Billion USD | 106.33% |
| 2017 FY | - USD | -8.33% |
| 2017 Q1 | 3.52 Billion USD | 938.64% |
| 2017 Q2 | 3.97 Billion USD | 13.01% |
| 2017 Q3 | 1.69 Billion USD | -57.53% |
| 2016 Q3 | 4.39 Billion USD | 29.45% |
| 2016 FY | - USD | 13.15% |
| 2016 Q2 | 3.39 Billion USD | -2.58% |
| 2016 Q4 | 339 Million USD | -92.29% |
| 2016 Q1 | 3.48 Billion USD | 15.55% |
| 2015 Q4 | 3.01 Billion USD | -32.55% |
| 2015 Q2 | 3.49 Billion USD | 4.08% |
| 2015 Q1 | 3.35 Billion USD | -75.95% |
| 2015 FY | - USD | -58.51% |
| 2015 Q3 | 4.47 Billion USD | 27.95% |
| 2014 FY | - USD | 130.17% |
| 2014 Q3 | 3.72 Billion USD | -7.12% |
| 2014 Q2 | 4.01 Billion USD | -4.22% |
| 2014 Q1 | 4.19 Billion USD | 5.94% |
| 2014 Q4 | 13.96 Billion USD | 274.47% |
| 2013 FY | - USD | -22.7% |
| 2013 Q1 | 3.73 Billion USD | 8.0% |
| 2013 Q4 | 3.95 Billion USD | -8.53% |
| 2013 Q3 | 4.32 Billion USD | 30.66% |
| 2013 Q2 | 3.31 Billion USD | -11.45% |
| 2012 Q3 | 4.27 Billion USD | -11.09% |
| 2012 Q4 | 3.46 Billion USD | -19.09% |
| 2012 FY | - USD | 10.32% |
| 2012 Q1 | 4.75 Billion USD | 13.99% |
| 2012 Q2 | 4.81 Billion USD | 1.16% |
| 2011 Q1 | 4.2 Billion USD | 159.67% |
| 2011 Q4 | 4.17 Billion USD | -6.66% |
| 2011 Q2 | 4.33 Billion USD | 2.92% |
| 2011 Q3 | 4.47 Billion USD | 3.23% |
| 2011 FY | - USD | -14.21% |
| 2010 Q2 | 3.45 Billion USD | 24.77% |
| 2010 Q3 | 3.55 Billion USD | 2.98% |
| 2010 Q4 | 1.62 Billion USD | -54.46% |
| 2010 FY | - USD | 327.46% |
| 2010 Q1 | 2.77 Billion USD | 97.86% |
| 2009 Q3 | 2.75 Billion USD | 7.31% |
| 2009 Q4 | 1.4 Billion USD | -49.19% |
| 2009 Q2 | 2.56 Billion USD | 10.69% |
| 2009 Q1 | 2.31 Billion USD | 18.68% |
| 2009 FY | - USD | -173.62% |
| 2008 Q4 | 1.95 Billion USD | -30.01% |
| 2008 FY | - USD | -47.86% |
| 2008 Q3 | 2.79 Billion USD | 7.53% |
| 2008 Q1 | 2.86 Billion USD | -63.06% |
| 2008 Q2 | 2.59 Billion USD | -9.32% |
| 2007 Q3 | 1.58 Billion USD | -18.85% |
| 2007 FY | - USD | 118.35% |
| 2007 Q1 | 1.77 Billion USD | 96.66% |
| 2007 Q2 | 1.95 Billion USD | 10.42% |
| 2007 Q4 | 7.75 Billion USD | 388.72% |
| 2006 Q4 | 900.3 Million USD | -18.53% |
| 2006 FY | - USD | -22.82% |
| 2006 Q3 | 1.1 Billion USD | -43.26% |
| 2006 Q2 | 1.94 Billion USD | -4.06% |
| 2006 Q1 | 2.03 Billion USD | 9.2% |
| 2005 Q3 | 1.88 Billion USD | -5.5% |
| 2005 Q2 | 1.99 Billion USD | -1.89% |
| 2005 Q1 | 2.03 Billion USD | 61.44% |
| 2005 FY | - USD | 2.26% |
| 2005 Q4 | 1.85 Billion USD | -1.31% |
| 2004 Q4 | 1.25 Billion USD | -30.62% |
| 2004 Q3 | 1.81 Billion USD | -30.38% |
| 2004 Q2 | 2.6 Billion USD | 36.92% |
| 2004 Q1 | 1.9 Billion USD | 1.92% |
| 2004 FY | - USD | -19.69% |
| 2003 Q4 | 1.86 Billion USD | -31.58% |
| 2003 FY | - USD | -14.72% |
| 2003 Q2 | 2.25 Billion USD | -6.85% |
| 2003 Q3 | 2.72 Billion USD | 21.14% |
| 2003 Q1 | 2.41 Billion USD | -20.34% |
| 2002 Q3 | 2.49 Billion USD | -8.0% |
| 2002 FY | - USD | 1.2% |
| 2002 Q4 | 3.03 Billion USD | 21.47% |
| 2002 Q2 | 2.71 Billion USD | 10.93% |
| 2002 Q1 | 2.44 Billion USD | -15.15% |
| 2001 Q3 | 2.94 Billion USD | 10.42% |
| 2001 Q4 | 2.88 Billion USD | -2.0% |
| 2001 FY | - USD | 13.61% |
| 2001 Q1 | 2.44 Billion USD | -13.44% |
| 2001 Q2 | 2.66 Billion USD | 9.29% |
| 2000 Q3 | 2.43 Billion USD | 4.11% |
| 2000 Q2 | 2.33 Billion USD | 14.54% |
| 2000 Q1 | 2.03 Billion USD | -12.58% |
| 2000 Q4 | 2.81 Billion USD | 15.9% |
| 2000 FY | - USD | 27.71% |
| 1999 Q3 | 1.93 Billion USD | 17.66% |
| 1999 Q2 | 1.64 Billion USD | -4.96% |
| 1999 FY | - USD | 43.17% |
| 1999 Q4 | 2.33 Billion USD | 20.8% |
| 1999 Q1 | 1.72 Billion USD | 1.72% |
| 1998 Q4 | 1.69 Billion USD | 39.28% |
| 1998 Q2 | 1.58 Billion USD | 10.83% |
| 1998 FY | - USD | -6.69% |
| 1998 Q3 | 1.21 Billion USD | -1.25% |
| 1998 Q1 | 1.11 Billion USD | -46.99% |
| 1997 Q2 | 1.3 Billion USD | 16.11% |
| 1997 FY | - USD | 11.25% |
| 1997 Q3 | 1.1 Billion USD | -15.14% |
| 1997 Q4 | 2.1 Billion USD | 89.44% |
| 1997 Q1 | 1.12 Billion USD | -40.0% |
| 1996 FY | - USD | 8.43% |
| 1996 Q2 | 1.14 Billion USD | 24.88% |
| 1996 Q3 | 1.13 Billion USD | -0.97% |
| 1996 Q4 | 1.87 Billion USD | 65.43% |
| 1996 Q1 | 917.1 Million USD | -44.06% |
| 1995 Q1 | 881.3 Million USD | -48.07% |
| 1995 Q3 | 1.08 Billion USD | 0.8% |
| 1995 FY | - USD | -7.4% |
| 1995 Q4 | 1.63 Billion USD | 51.31% |
| 1995 Q2 | 1.07 Billion USD | 21.96% |
| 1994 Q4 | 1.69 Billion USD | 46.86% |
| 1994 FY | - USD | 2.11% |
| 1994 Q1 | 974 Million USD | -60.37% |
| 1994 Q2 | 1.22 Billion USD | 25.88% |
| 1994 Q3 | 1.15 Billion USD | -5.76% |
| 1993 Q1 | 867.2 Million USD | 3.46% |
| 1993 Q2 | 201.8 Million USD | -76.73% |
| 1993 FY | - USD | 32.28% |
| 1993 Q4 | 2.45 Billion USD | 144.15% |
| 1993 Q3 | 1 Billion USD | 398.86% |
| 1992 Q1 | 808.7 Million USD | 3.91% |
| 1992 Q2 | 914 Million USD | 13.02% |
| 1992 FY | - USD | 12.79% |
| 1992 Q3 | 858.5 Million USD | -6.07% |
| 1992 Q4 | 838.2 Million USD | -2.36% |
| 1991 Q4 | 778.3 Million USD | 0.92% |
| 1991 FY | - USD | 16.04% |
| 1991 Q3 | 771.2 Million USD | -11.21% |
| 1991 Q2 | 868.6 Million USD | 13.31% |
| 1991 Q1 | 766.6 Million USD | 10.62% |
| 1990 FY | - USD | 18.53% |
| 1990 Q4 | 693 Million USD | 5.54% |
| 1990 Q3 | 656.6 Million USD | -2.73% |
| 1990 Q2 | 675 Million USD | 16.5% |
| 1990 Q1 | 579.4 Million USD | 5.77% |
| 1989 Q1 | 1.57 Billion USD | 161.9% |
| 1989 Q4 | 547.8 Million USD | -3.4% |
| 1989 Q3 | 567.1 Million USD | -64.23% |
| 1989 FY | - USD | 16.63% |
| 1989 Q2 | 1.58 Billion USD | 0.88% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbbVie Inc. | 26.35 Billion USD | 73.795% |
| Bristol-Myers Squibb Company | 19.41 Billion USD | 64.428% |
| Bristol-Myers Squibb Company Ce | 19.41 Billion USD | 64.428% |
| Johnson & Johnson | 23.72 Billion USD | 70.887% |
| Eli Lilly and Company | 8.56 Billion USD | 19.384% |
| Novartis AG | 18.28 Billion USD | 62.228% |
| Organon & Co. | 1.43 Billion USD | -380.989% |
| Pfizer Inc. | 9.55 Billion USD | 27.728% |